psalexa
SearchBar Icon

Global Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PD-L1) Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 – Industry Insights by Drug (Opdivo, Keytruda, Tecentriq, Durvalumab, Avelumab), by Mechanism of Action (PD-1 Inhibitor, PD-L1 Inhibitor)

PD-1 & PD-L1 Inhibitors Pipeline Analysis
Published:  January 2017 Report Code:  LS10752 Available Format:   Pages:  168

Note: This report can also be updated as of date and delivered within 1-2 working days of purchase confirmation

The research offers pipeline analysis as of the year 2016, historical market size for the year 2014 and 2015, estimate for the year 2016 and forecast for the period 2017 – 2025 in terms of U.S. dollars.

GLOBAL PD-1 & PD-L1 INHIBITORS PIPELINE ANALYSIS

  • By mechanism of action (MoA)
  • By molecule type
  • By route of administration
  • By company
  • By phase

GLOBAL PD-1 & PD-L1 INHIBITORS MARKET

  • By drug
  • By MoA
Plane  Enquire Before Purchase
Place an order
alert The report will be delivered in PDF format without printing rights. It is recommended for a single user.
USD 4700
alert The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.
USD 5600
alert The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.
USD 8450
Related Reports